Lushang Freda Pharmaceutical Co.,Ltd. (SHA:600223)
China
· Delayed Price · Currency is CNY 7.80
-0.17 (-2.13%)
May 30, 2025, 2:45 PM CST
SHA:600223 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | May '25 May 29, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 7,939 | 7,685 | 9,790 | 10,765 | 13,371 | 8,595 | Upgrade
|
| Market Cap Growth | -10.78% | -21.50% | -9.06% | -19.49% | 55.57% | 1.86% | Upgrade
|
| Enterprise Value | 6,130 | 5,881 | 12,411 | 15,213 | 21,219 | 16,887 | Upgrade
|
| Last Close Price | 7.81 | 7.56 | 9.41 | 10.34 | 12.79 | 8.12 | Upgrade
|
| PE Ratio | 33.95 | 31.56 | 32.27 | 236.84 | 36.95 | 13.46 | Upgrade
|
| Forward PE | 26.54 | 6.60 | 6.60 | 6.60 | 6.60 | 6.60 | Upgrade
|
| PS Ratio | 2.00 | 1.93 | 2.14 | 0.83 | 1.08 | 0.63 | Upgrade
|
| PB Ratio | 1.64 | 1.61 | 2.09 | 1.93 | 2.06 | 1.32 | Upgrade
|
| P/TBV Ratio | 2.07 | 2.03 | 2.64 | 3.20 | 3.07 | 2.32 | Upgrade
|
| P/FCF Ratio | - | 107.58 | 37.25 | 12.94 | 2.04 | 2.00 | Upgrade
|
| P/OCF Ratio | 108.36 | 33.61 | 20.65 | 10.79 | 1.95 | 1.93 | Upgrade
|
| EV/Sales Ratio | 1.54 | 1.48 | 2.71 | 1.18 | 1.72 | 1.24 | Upgrade
|
| EV/EBITDA Ratio | 20.79 | 19.07 | 34.14 | 21.98 | 29.09 | 19.82 | Upgrade
|
| EV/EBIT Ratio | 29.77 | 27.39 | 54.51 | 26.43 | 33.32 | 22.05 | Upgrade
|
| EV/FCF Ratio | -83.16 | 82.33 | 47.23 | 18.29 | 3.23 | 3.94 | Upgrade
|
| Debt / Equity Ratio | 0.07 | 0.06 | 0.47 | 1.39 | 1.43 | 1.76 | Upgrade
|
| Debt / EBITDA Ratio | 1.13 | 0.91 | 5.81 | 11.09 | 12.71 | 13.46 | Upgrade
|
| Debt / FCF Ratio | - | 4.00 | 8.30 | 9.30 | 1.41 | 2.67 | Upgrade
|
| Asset Turnover | 0.64 | 0.58 | 0.14 | 0.22 | 0.20 | 0.23 | Upgrade
|
| Inventory Turnover | 3.53 | 3.49 | 0.11 | 0.21 | 0.20 | 0.24 | Upgrade
|
| Quick Ratio | 3.07 | 3.15 | 2.24 | 0.12 | 0.13 | 0.12 | Upgrade
|
| Current Ratio | 3.71 | 3.75 | 2.49 | 1.10 | 1.15 | 1.17 | Upgrade
|
| Return on Equity (ROE) | 5.96% | 6.26% | 7.15% | 1.08% | 6.05% | 11.39% | Upgrade
|
| Return on Assets (ROA) | 2.06% | 1.94% | 0.43% | 0.60% | 0.65% | 0.81% | Upgrade
|
| Return on Capital (ROIC) | 2.43% | 2.25% | 1.41% | 2.47% | 2.36% | 2.87% | Upgrade
|
| Return on Capital Employed (ROCE) | 4.20% | 4.40% | 4.20% | 7.30% | 6.20% | 7.00% | Upgrade
|
| Earnings Yield | 2.96% | 3.17% | 3.10% | 0.42% | 2.71% | 7.43% | Upgrade
|
| FCF Yield | -0.93% | 0.93% | 2.68% | 7.73% | 49.11% | 49.92% | Upgrade
|
| Dividend Yield | 1.54% | 1.46% | 1.06% | 1.06% | 0.86% | 2.46% | Upgrade
|
| Payout Ratio | 70.46% | 75.38% | 160.84% | 2585.08% | 556.88% | 354.89% | Upgrade
|
| Buyback Yield / Dilution | -1.36% | -0.34% | 11.01% | -9.90% | -2.00% | -0.05% | Upgrade
|
| Total Shareholder Return | 0.15% | 1.12% | 12.07% | -8.84% | -1.14% | 2.42% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.